Andy Yeung

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Andy Yeung and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Andy

Andy Yeung

Chief Technology Officer, Founder

Asher Biotherapeutics

Andy Yeung currently serves as the Chief Technology Officer of Asher Biotherapeutics, responsible for the engineering and development of antibody and cytokine candidates. Previously Andy spent ten years at Pfizer, leading protein engineering efforts for various programs including CD3 bispecific, CAR T, and immuno-oncology (antibodies and cytokines). Prior to Pfizer, Andy was a post-doctoral fellow in the Antibody Engineering Department at Genentech. Andy received his Ph.D. in Chemical engineering and M.S. in Chemical Engineering Practice from Massachusetts Institute of Technology, and a B.Sc. in Chemical Engineering from University of Wisconsin-Madison.

Talks About
#technology #biotherapeutics

Preferred Locations
#NorthAmerica

Speaking Engagements

Emerging Technologies for IO Targeting and Discovery

Paid

In recent years, Immunotherapy has been at the forefront of oncology research. However, this has not been without issues. Some of which include applications to solid tumors, regulating biodistribution, and serious side effects. During this conference, we discuss tumor microenvironment modulation, improving delivery systems, novel approaches, and ov

08-09 August 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Andy Yeung

Chief Technology Officer, Founder

Speaking Engagements

Emerging Technologies for IO Targeting and Discovery